Carrageenan‐induced acute inflammation in the mouse air pouch synovial model. Role of tumour necrosis factor
Open Access
- 1 January 1997
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 6 (1) , 32-38
Abstract
We used the mouse air pouch model of inflammation to study the interaction between cytokines, prostaglandin E2 (PGE2) and cell migration during the various phases of acute local inflammation induced by carrageenan. In serum, the levels of interleukin 1 (IL‐1), interleukin 6 (IL‐6), tumour necrosis factor (TNF), serum amiloid‐A (SAA) and Fe++ were never different from controls, indicating that no systemic inflammatory changes were induced. Locally the exudate volume and the number of leukocytes recruited into the pouch increased progressively until 7 days after carrageenan. The same was true for PGE2 production. We could not measure IL‐1 but the production of IL‐6 and TNF reached a maximum after 5‐24 h then quickly decreased. Anti‐TNF antibodies inhibited cell migration by 50% 24 h after treatment. Pretreatment with interleukin 10 (IL‐10) inhibited TNF production almost completely and cell migration by 60%. Carrageenan‐induced inflammation was modulated by anti‐inflammatory drugs. Pretreatment with dexamethasone (DEX) or indomethacin (INDO) inhibited cell migration and reduced the concentration of TNF in the exudate. Production of PGE2 or vascular permeability did not correlate with the number of cells in the pouch. Local TNF seems to play an important role in this model, particularly for leukocyte migration in the first phase of the inflammatory process. In conclusion, the air pouch seems to be a good model for studying the regulation of the early events of local inflammation, particularly the role of cytokines and cell migration.Keywords
This publication has 28 references indexed in Scilit:
- Cyclooxygenase inhibitors enhance tumour necrosis factor production and mortality in murine endotoxic shockCytokine, 1994
- Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor αArthritis & Rheumatism, 1993
- Role of tumor necrosis factor-α in disease states and inflammationCritical Care Medicine, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.Journal of Experimental Medicine, 1993
- Changes in histamine and prostaglandins in acute inflammatory air pouch in miceInflammation Research, 1989
- Mast cells in newly formed lining tissue during acute inflammation: a six day air pouch model in the mouse.Annals of the Rheumatic Diseases, 1986
- Studies of eicosanoid production in the air pouch model of synovial inflammationInflammation Research, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Arachidonic acid metabolites regulate interleukin-1 productionBiochemical and Biophysical Research Communications, 1985
- Increased inflammatory reactivity in newly formed lining tissueThe Journal of Pathology, 1983